Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)

Dedifferentiated endometrial carcinoma (DDEC) is defined as an undifferentiated carcinoma admixed with differentiated endometrioid carcinoma (Grade 1 or 2). It has poor prognosis compared with Grade 3 endometrioid adenocarcinoma and is often associated with the loss of mismatch repair (MMR) proteins...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Mol Sci
Autori principali: Ono, Ruriko, Nakayama, Kentaro, Nakamura, Kohei, Yamashita, Hitomi, Ishibashi, Tomoka, Ishikawa, Masako, Minamoto, Toshiko, Razia, Sultana, Ishikawa, Noriyoshi, Otsuki, Yoshiro, Nakayama, Satoru, Onuma, Hideyuki, Kurioka, Hiroko, Kyo, Satoru
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6696376/
https://ncbi.nlm.nih.gov/pubmed/31370215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20153744
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi